Revance Therapeutics, Inc. Business Finance Contracts & Agreements
33 Contracts & Agreements
- Indenture Agreements (1 contract)
- Investor Rights Agreements (3)
- Loan Agreements (4)
- Note Agreements (1)
- Stock Agreements (9)
- Underwriting Agreements (8)
- Warrant Agreements (7)
- Underwriting Agreement, dated March 4, 2024, by and between the Company and the Underwriter (Filed With SEC on March 5, 2024)
- Form of Restricted Stock Unit Agreement and Grant Notice under Amended and Restated Revance Therapeutics, Inc. 2014 Inducement Plan (Filed With SEC on February 28, 2023)
- Underwriting Agreement, dated September 12, 2022, by and among the Company and the Underwriters (Filed With SEC on September 14, 2022)
- Note Purchase Agreement dated March 18, 2022 among Revance Therapeutics, Inc., certain subsidiaries of Revance Therapeutics, Inc., Athyrium Buffalo LP and the purchasers from time... (Filed With SEC on May 10, 2022)
- Form of Restricted Stock Agreement and Grant Notice under Amended and Restated Revance Therapeutics, Inc. 2014 Inducement Plan (Filed With SEC on February 25, 2021)
- Loan Agreement, dated May 18, 2020, by and between Revance Therapeutics, Inc. and Hint, Inc (Filed With SEC on June 10, 2020)
- Indenture, dated as of February 14, 2020, by and between Revance Therapeutics, Inc. and U.S. Bank National Association, as Trustee (Filed With SEC on February 14, 2020)
- Underwriting Agreement, dated December 4, 2019, by and among the Company and the Underwriters (Filed With SEC on December 4, 2019)
- Underwriting Agreement, dated January 16, 2019, by and among the Company and the Underwriters (Filed With SEC on January 17, 2019)
- Underwriting Agreement, dated December 6, 2017, by and among the Company, the Selling Stockholders and the Underwriters (Filed With SEC on December 7, 2017)
- REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE (Filed With SEC on March 4, 2016)
- REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE (Filed With SEC on November 10, 2015)
- REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on November 10, 2015)
- 3,250,000 Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on November 4, 2015)
- REVANCE THERAPEUTICS, INC. $50,000,000 COMMON STOCK SALES AGREEMENT (Filed With SEC on March 4, 2015)
- REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE CAPITAL STOCK (Filed With SEC on March 4, 2015)
- SECOND AMENDMENT TO LOAN AND LEASE AGREEMENT (Filed With SEC on March 4, 2015)
- FIRST AMENDMENT TO LOAN ANDLEASE AGREEMENT (Filed With SEC on December 22, 2014)
- REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN RESTRICTED STOCK GRANT NOTICE (Filed With SEC on August 29, 2014)
- REVANCE THERAPEUTICS, INC. 2014 INDUCEMENT PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on August 29, 2014)
- [] Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 16, 2014)
- WARRANT AGREEMENT To Purchase Shares of Preferred Stock of REVANCE THERAPEUTICS, INC. Dated as of[ ] (the Effective Date) (Filed With SEC on January 27, 2014)
- REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SHARES OF SERIES PREFERRED STOCK (Filed With SEC on January 27, 2014)
- REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE CAPITAL STOCK (Filed With SEC on January 27, 2014)
- REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SERIES D PREFERRED STOCK (Filed With SEC on January 27, 2014)
- REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE SHARES OF SERIES PREFERRED STOCK (Filed With SEC on January 27, 2014)
- REVANCE THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 27, 2014)
- AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on January 27, 2014)
- REVANCE THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:JANUARY 22, 2014 APPROVED BY THE STOCKHOLDERS:JANUARY 23, 2014 (Filed With SEC on January 27, 2014)
- REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 27, 2014)
- [] Shares Revance Therapeutics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 27, 2014)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on December 31, 2013)
- REVANCE THERAPEUTICS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on December 31, 2013)
